Global Nuclear Medicine Radioisotope Markets 2021-2027: Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Others – Technetium-99m (Tc-99m) to Account for $24.8 Billion – ResearchAndMarkets.com

DUBLIN–()–The “Nuclear Medicine Radioisotope – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s providing.

Global Nuclear Medicine Radioisotope Market to Reach $36.9 Billion by 2027

Amid the COVID-19 disaster, the worldwide marketplace for Nuclear Medicine Radioisotope estimated at US$17.1 Billion within the yr 2020, is projected to achieve a revised measurement of US$36.9 Billion by 2027, rising at a CAGR of 11.6% over the evaluation interval 2020-2027.

Technetium-99m (Tc-99m), one of many segments analyzed within the report, is projected to file a 12.3% CAGR and attain US$24.8 Billion by the tip of the evaluation interval. After an early evaluation of the enterprise implications of the pandemic and its induced financial disaster, development within the Thallium-201 (Tl-201) phase is readjusted to a revised 10.6% CAGR for the subsequent 7-year interval.

The U.S. Market is Estimated at $5.1 Billion, While China is Forecast to Grow at 11.1% CAGR

The Nuclear Medicine Radioisotope market within the U.S. is estimated at US$5.1 Billion within the yr 2020. China, the world’s second largest financial system, is forecast to achieve a projected market measurement of US$6.4 Billion by the yr 2027 trailing a CAGR of 11.1% over the evaluation interval 2020 to 2027.

Among the opposite noteworthy geographic markets are Japan and Canada, every forecast to develop at 10.3% and 9.7% respectively over the 2020-2027 interval. Within Europe, Germany is forecast to develop at roughly 8.3% CAGR.

Iodine (I-123) Segment to Record 11.3% CAGR

In the worldwide Iodine (I-123) phase, USA, Canada, Japan, China and Europe will drive the 11.1% CAGR estimated for this phase. These regional markets accounting for a mixed market measurement of US$1.2 Billion within the yr 2020 will attain a projected measurement of US$2.5 Billion by the shut of the evaluation interval.

China will stay among the many quickest rising on this cluster of regional markets. Led by nations resembling Australia, India, and South Korea, the market in Asia-Pacific is forecast to achieve US$4.3 Billion by the yr 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 42 Featured):

  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • NTP Radioisotopes SOC Ltd.
  • Positron Corporation
  • Siemens Healthineers

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2018 via 2027 and % CAGR
  • World Historic Review for Nuclear Medicine Radioisotope by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 via 2017 and % CAGR
  • World 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Iodine (I-123) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Other Type of Radioisotopes by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Oncology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Cardiology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Lymphoma by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Thyroid by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • World 15-Year Perspective for Neurology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 42

For extra details about this report go to https://www.researchandmarkets.com/r/df689t.

LEAVE A REPLY

Please enter your comment!
Please enter your name here